EFG International’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.57M Buy
79,256
+705
+0.9% +$40.5K 0.08% 214
2026
Q1
$4.76M Buy
78,551
+16,946
+28% +$988K 0.1% 187
2025
Q4
$3.32M Buy
+61,605
New +$2.96M 0.06% 260

Other funds holding BMY

EFG International's BMY Position: Q2 2026 in Review

EFG International increased its Bristol-Myers Squibb (BMY) stake by 0.9% in Q2 2026, buying an estimated $40.5K and bringing the position to 79,256 shares worth $4.57M. The position accounts for 0.08% of the portfolio, ranked #214.

EFG International first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.76M in Q1 2026. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • EFG International held 79,256 shares of Bristol-Myers Squibb worth $4.57M as of Q2 2026.
  • EFG International bought 705 Bristol-Myers Squibb shares in Q2 2026, an estimated $40.5K.
  • Bristol-Myers Squibb made up 0.08% of EFG International's portfolio in Q2 2026, its #214 holding.
  • EFG International first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • EFG International's Bristol-Myers Squibb position peaked at $4.76M in Q1 2026.
  • 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.